Hormone Receptor Status Influences the Locoregional Benefit of Trastuzumab in Patients With Nonmetastatic Breast Cancer

D.M. Arsenault(Radiation Oncology Associates), Jean L. Wright(University of North Carolina at Chapel Hill)
Breast Diseases A Year Book Quarterly
January 1, 2013
Cited by 1


Related Papers